1. The ubiquitin E3/E4 ligase, UBE4A, fine-tunes protein ubiquitylation and accumulation at sites of DNA damage facilitating double-strand break repair
- Author
-
Isabel Soria-Bretones, Jong Bok Yoon, Yoon Park, Eli Rothenberg, Keren Baranes-Bachar, Graham Dellaire, Wei Li, Dylan A. Reid, Yael Ziv, Tom Misteli, Yosef Shiloh, Judith Oehler, Chao Liu, Kristijan Ramadan, Ty C. Voss, Dudley Chung, Adva Levy-Barda, Pablo Huertas, Universidad de Sevilla. Departamento de Genética, Adelson Medical Research Foundation, Israel Science Foundation, A-T Children's Project, National Natural Science Foundation of China, Israel Cancer Research Fund, National Institutes of Health (US), National Cancer Institute (US), Swiss National Science Foundation, Medical Research Council (UK), Natural Sciences and Engineering Research Council of Canada, Ministerio de Economía y Competitividad (España), European Research Council, American Cancer Society, and Universidad de Sevilla
- Subjects
0301 basic medicine ,Double-strand breaks ,DNA damage ,Ubiquitin-Protein Ligases ,UBE4A ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Ubiquitin ,Downregulation and upregulation ,Genome stability ,ubiquitin ,Humans ,DNA Breaks, Double-Stranded ,Histone Chaperones ,Molecular Biology ,Ubiquitins ,health care economics and organizations ,chemistry.chemical_classification ,DNA ligase ,double-strand breaks ,biology ,BRCA1 Protein ,Ubiquitination ,Nuclear Proteins ,Recombinational DNA Repair ,Cell Biology ,Double Strand Break Repair ,3. Good health ,Ubiquitin ligase ,Cell biology ,body regions ,DNA-Binding Proteins ,030104 developmental biology ,chemistry ,biology.protein ,Homologous recombination ,Carrier Proteins ,DNA ,genome stability ,HeLa Cells - Abstract
Double-strand breaks (DSBs) are critical DNA lesions that robustly activate the elaborate DNA damage response (DDR) network. We identified a critical player in DDR fine-tuning: the E3/E4 ubiquitin ligase UBE4A. UBE4A’s recruitment to sites of DNA damage is dependent on primary E3 ligases in the DDR and promotes enhancement and sustainment of K48- and K63-linked ubiquitin chains at these sites. This step is required for timely recruitment of the RAP80 and BRCA1 proteins and proper organization of RAP80- and BRCA1-associated protein complexes at DSB sites. This pathway is essential for optimal end resection at DSBs, and its abrogation leads to upregulation of the highly mutagenic alternative end-joining repair at the expense of error-free homologous recombination repair. Our data uncover a critical regulatory level in the DSB response and underscore the importance of fine-tuning the complex DDR network for accurate and balanced execution of DSB repair., Work in the Y.S. laboratory is funded by research grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the A-T Children’s Project, the Israel Science Foundation Joint ISF-NSFC Research Program (jointly funded by the Israel Science Foundation and the National Natural Science Foundation of China - Grant No. 998/14), and the Israel Cancer Research Fund (Professorship). T.M. and T.C.V. were supported by funding from the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, and the Center for Cancer Research. Work in the K.R. laboratory is supported by the Swiss National Science Foundation (31003A_141197) and the Medical Research Council, UK (MC_PC_12001/1). Work in the G.D. laboratory is supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 05616). Work in the P.H. lab was supported by an R+D+I grant from the Spanish Ministry of Economy and Competitivity (SAF2013-43255-P) and an ERC starting grant (DSBRECA). Work in the E.R. laboratory is supported by NIH grants GM108119 and CA187612 and American Cancer Society grant ACS130304-RSG-16-241-01-DMC. I.S.-B. is the recipient of a Ph.D. fellowship from the University of Sevilla. D.C. was supported by a Nova Scotia graduate scholarship. K.B.B. is a Jack and Florence Berlin fellow. Y.S. is a Research Professor of the Israel Cancer Research Fund.
- Published
- 2018